Posts Tagged ‘california medi-cal’

Treatment with vitamin D reduced the size of uterine fibroids in laboratory rats predisposed to developing the benign tumors, reported researchers funded by the National Institutes of Health.

Visit the Blog and you’ll discover useful, timely, and interesting government information and services. Here’s what readers are saying about the blog: “uses language the average person can understand”; “concise and trusted information”; “knowledgeable answers to government related questions.”

Christine Grady, Ph.D., was recently named chief of the Department of Bioethics of the National Institutes of Health (NIH) Clinical Center.

Christine Grady, Ph.D., was recently named chief of the Department of Bioethics of the National Institutes of Health (NIH) Clinical Center.

Results of an intermediate stage clinical trial of several dozen people provides evidence that a method that has worked for treating patients with metastatic melanoma can also work for patients with metastatic synovial cell sarcoma, one of the most common soft tissue tumors in adolescents and young adults. This study is the first to use genetically modified immune cells, in a technique known as adoptive therapy, to cause cancer regression in patients with a solid cancer as opposed to melanoma. This approach represents a method for obtaining immune cells from any cancer patient and converting them into ones that can recognize cancer cells expressing the target antigen, NY-ESO-1, according to researchers at the National Cancer Institute.

Scientists have discovered that molecules called reactive oxygen species (ROS) produced by the energy factories, or mitochondria, in cells, may play a role in a rare inherited disorder in which uncontrolled inflammation damages the body’s tissues. Their research in human and mouse cells suggests that blocking these molecules could reduce inflammation in TNF receptor-associated periodic syndrome (TRAPS) and possibly other inflammatory diseases.

Do you file your federal taxes electronically, or are you still using the paper forms? The IRS (Internal Revenue Service) says that almost 100 million taxpayers e-filed their taxes last year. Even I’m surprised that many of us e-file. There are three ways to e-file:  Free File – You can go to and use the Free File program if your income was $58,000 or less. If you’re the type of person that prefers to fill in the forms yourself, you can do that online too with the Free File Fillable Forms program. With fillable forms, you choose the forms you need, fill them in, sign electronically and e-file your return.  e-file – You can do it yourself and buy tax preparation software, prepare your own return, and press “send to e-file.”  Find a tax preparer that is an authorized IRS e-file provider and have your tax preparer e-file for you. Nearly all tax preparers use e-file, and many are now required by law to e-file.  E-filing can even help you avoid the processing delay caused by the tax legislation enacted late last year. If you’re somebody who claims itemized deductions on Schedule A, the higher education tuition and fees deduction on Form 8917, or the educator expenses deduction, you can e-file and get a head start because many major software providers have announced they will accept these impacted returns immediately. The software providers will hold onto the returns and then electronically submit them after the IRS systems open on Feb. 14.  This year you can even track your refund with your smartphone! The free IRS2Go app is available in the Apple App Store and the Android Marketplace.

Researchers at the National Institutes of Health and the University of Hong Kong have discovered that high levels of a particular protein in cancer cells are a reliable indicator that a cancer will spread.

Members of the media are invited to attend a National Institutes of Health conference focused on transforming computed tomography (CT) technology and its use to achieve minimal public health risks from radiation exposure. A specific goal of this conference is to identify the technological steps and associated research required to reduce the radiation dose from routine CT exams to less than 1 mSv (millisievert, the unit used to measure the amount of ionizing radiation absorbed by human tissues). Additional goals in the near-term are improving our understanding and management of radiation exposure, and defining steps to achieve best technical and clinical practices.

Clinical researchers at the National Institutes of Health’s Undiagnosed Diseases Program (UDP) have identified the genetic cause of a rare and debilitating vascular disorder not previously explained in the medical literature. The adult-onset condition is associated with progressive and painful arterial calcification affecting the lower extremities, yet spares patients’ coronary arteries. The new disease finding was published today in the New England Journal of Medicine.

Contact Us | Privacy Statement